In an effort to get critical parts of the US government funded, the House of Representatives is going to vote today on a bill, H.R. 265, that would pay for health inspectors, food stamps, and drug approvals, according to Politico.
It would also would renew the prohibition on genetically modified human beings in the US.
Baby ban: Since 2015, the US has adopted language in funding bills that prohibits the Food and Drug Administration from considering any application to create IVF children from embryos that have been genetically modified. But it has to be renewed every year.
What’s prohibited: The ban covers gene-edited babies like those allegedly born recently in China, who had a gene removed to make them resistant to HIV. It also blocks a technique, known as “three-parent babies,” that is being used to try and prevent mitochondrial disease.
The rule is one reason such efforts are occuring first in other countries, including China and Ukraine, not in the US.
Strongly opposed: The FDA commissioner, Scott Gottlieb, has left no doubt he’s deeply opposed to softening the CRISPR baby rule. In November he tweeted:
Certain uses of science should be judged intolerable, and cause scientists to be cast out. The use of CRISPR to edit human embryos or germ line cells should fall into that bucket. Anything less puts the science and the entire scientific enterprise at risk.
Lacks subtlety: By blocking any-and-all DNA changes to an embryo, I. Glenn Cohen, a professor at Harvard Law School, says American legislation has taken a "meat axe" approach when what's needed is a "scalpel" to separate good uses of technology from bad. Congress is again missing a chance “to craft a better, more subtle policy” that could allow real public debate on new reproductive technologies, Cohen says.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
A new storage technique could vastly expand the number of livers available for transplant
It allows donor livers to be held for days—significantly longer than the standard now–and even treated if they are damaged.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.